The Trastuzumab Injection Market growth continues to accelerate as targeted cancer therapies gain prominence in the global oncology landscape. With HER2-positive breast and gastric cancers representing significant patient populations worldwide, the demand for biosimilar and originator trastuzumab formulations is steadily rising. Expanding oncology infrastructure, increasing adoption of...